HomeMedroxyprogesterone Acetate SuspensionMedroxyprogesterone Acetate Suspension + Pegvaliase Pqpz

Does Medroxyprogesterone Acetate Suspension Interact with Pegvaliase Pqpz?

Medroxyprogesterone Acetate Suspension and Pegvaliase Pqpz have a major drug interaction according to U.S. FDA drug labeling data. Concomitant use may cause hypersensitivity reactions including anaphylaxis. Two patients experienced hypersensitivity reactions within 10-15 minutes of medroxyprogesterone acetate injection after PEGVALIASE-PQPZ dosing, with one progressing to anaphylaxis. The mechanism involves anti-peg igg antibody formation from pegvaliase-pqpz may cross-react with peg-containing formulations like medroxyprogesterone acetate suspension (peg 3350). Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Major
Pegvaliase Pqpz Class
Phenylalanine Metabolizing Enzyme
Management
Close medical supervision required
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Medroxyprogesterone Acetate Suspension and Pegvaliase Pqpz occurs because anti-peg igg antibody formation from pegvaliase-pqpz may cross-react with peg-containing formulations like medroxyprogesterone acetate suspension (peg 3350). Clinically, this means concomitant use may cause hypersensitivity reactions including anaphylaxis. two patients experienced hypersensitivity reactions within 10-15 minutes of medroxyprogesterone acetate injection after pegvaliase-pqpz dosing, with one progressing to anaphylaxis. This is classified as a major interaction, meaning it could cause serious harm if not properly managed. Your healthcare provider may need to adjust dosages, substitute one medication, or increase monitoring frequency.

What To Tell Your Doctor or Pharmacist

If you are taking Medroxyprogesterone Acetate Suspension and your doctor is considering prescribing Pegvaliase Pqpz (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask how frequently you should be monitored while these are co-prescribed
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Medroxyprogesterone Acetate Suspension+💊 Pegvaliase Pqpz(Palynziq)

Severity & Interaction Details

⚠️
major
Use with caution — major interaction
Serious risk of clinically significant harm. Generally avoid; if used, monitor closely.
Severity scale
MinorContra
On record
Yes
Drug A class
Drug B class
Phenylalanine Metabolizing Enzyme
Source
NLP:pegvaliase-pqpz

What this means in plain English

Concomitant use may cause hypersensitivity reactions including anaphylaxis. Two patients experienced hypersensitivity reactions within 10-15 minutes of medroxyprogesterone acetate injection after PEGVALIASE-PQPZ dosing, with one progressing to anaphylaxis.

What the FDA label says

"Anti-PEG IgG antibody formation from PEGVALIASE-PQPZ may cross-react with PEG-containing formulations like medroxyprogesterone acetate suspension (PEG 3350)"

📖 Source: NLP:pegvaliase-pqpz

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Medroxyprogesterone Acetate Suspension and Pegvaliase Pqpz against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.